Einar K Rofstad
Overview
Explore the profile of Einar K Rofstad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naevdal G, Rofstad E, Soreide K, Evje S
J Biomech
. 2022 Nov;
145:111362.
PMID: 36368256
A remarkable feature in pancreatic cancer is the propensity to metastasize early, even for small, early stage cancers. We use a computer-based pancreatic model to simulate tumor progression behavior where...
2.
Gaustad J, Rofstad E
Front Oncol
. 2021 Oct;
11:722773.
PMID: 34621674
Intratumor heterogeneity is associated with aggressive disease and poor survival rates in several types of cancer. A novel method for assessing intratumor heterogeneity in medical images, named the spatial gradient...
3.
Gaustad J, Rofstad E
Front Oncol
. 2021 Jun;
11:668916.
PMID: 34094964
Tumor hypoxia is a major cause of treatment resistance and poor survival in locally-advanced cervical carcinoma (LACC). It has been suggested that and maps derived by dynamic contrast-enhanced magnetic resonance...
4.
Waldeland J, Gaustad J, Rofstad E, Evje S
J Theor Biol
. 2021 Jun;
526:110787.
PMID: 34087266
Recent preclinical studies have shown that interstitial fluid pressure (IFP) within tumors can be heterogeneous Andersen et al. (2019). In that study tumors of two xenograft models, respectively, HL-16 cervical...
5.
Gaustad J, Simonsen T, Hansem L, Rofstad E
Eur J Nucl Med Mol Imaging
. 2021 Feb;
48(10):3089-3100.
PMID: 33606081
Purpose: The purpose of the study was to demonstrate the performance and possible applications of an intravital microscopy assay using a standard fluorescence microscope. Methods: Melanoma and pancreatic ductal adenocarcinoma...
6.
Gaustad J, Hauge A, Wegner C, Simonsen T, Lund K, Hansem L, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32698525
Tumor hypoxia is associated with resistance to treatment, aggressive growth, metastatic dissemination, and poor clinical outcome in many cancer types. The potential of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to...
7.
Hauge A, Rofstad E
J Transl Med
. 2020 May;
18(1):207.
PMID: 32434573
Most tumors develop abnormal fibrotic regions consisting of fibroblasts, immune cells, and a dense extracellular matrix (ECM) immersed in a viscous interstitial fluid, and an abundant fibrotic tumor microenvironment (TME)...
8.
Lund K, Simonsen T, Kristensen G, Rofstad E
Radiat Oncol
. 2020 Apr;
15(1):79.
PMID: 32293487
Background: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) may provide biomarkers of the outcome of locally-advanced cervical carcinoma (LACC). There is, however, no agreement on how DCE-MR recordings should be analyzed....
9.
Simonsen T, Gaustad J, Rofstad E
J Transl Med
. 2020 Jan;
18(1):13.
PMID: 31915016
Background: Melanoma patients with metastatic growth in the meninges have poor prognosis and few treatment options. Although treatment with BRAF inhibitors or immune checkpoint inhibitors has provided promising results, most...
10.
Gaustad J, Simonsen T, Wegner C, Rofstad E
Front Oncol
. 2019 Sep;
9:845.
PMID: 31555596
The purpose of the study was to investigate vascularization, oxygenation, and the effect of sunitinib treatment in pancreatic ductal adenocarcinoma (PDAC). BxPC-3 and Capan-2 xenografts grown in dorsal window chambers...